Delivery Order SPE2DB24D2100-SPE2DB24FBASP
Award Date
4/2/24
Potential Completion Date
4/3/24
Potential Value
$25K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has a potential value of $8,977.17 and a completion date of February 2, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a potential value of $1,668.98. The contract has a completion date of March 6, 2024. Amerisourcebergen Drug Corp is the prime contractor and this delivery order is issued under a larger indefinite delivery contract (IDC) with DLA that has a potential value...
The U.S. Department of Defense (DoD) Medical Supply Chain (also known as the Defense Logistics Agency (DLA) Troop Support Medical) awarded a $2,230.84 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of GEMTESA 75 MG TABLET 90S. This order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen holds with the DLA, which serves as the primary vehicle for the company to deliver a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,367.17 firm fixed-price delivery order is for the provision of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of December 2, 2024 and was awarded on November 29, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide GEMTESA 75 MG TABLET 30S valued at $7,774.16. The contract has a completion date of February 23, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor for this award, which is issued under an existing indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,334.49 firm fixed-price delivery order is for the supply of GEMTESA 75 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $31,102.17 and a period of performance through February 20, 2024. The contract is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,465.10 firm fixed price delivery order is for the supply of GEMTESA 75 MG TABLET 30S, a pharmaceutical product, to support military treatment programs and facilities. This award does not utilize any small business set-aside designations. Amerisourcebergen Drug Corp...
This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4564676136 GEMTESA 75 MG TABLET 90S to the Defense Logistics Agency (DLA). The $37,866.52 firm fixed price delivery order contract has an ultimate completion date of May 22, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a $13,401.24 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a period of performance through August 27, 2024. This award is under DLA's broader Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA to procure a comprehensive range of medical...